The LeishVet group has formed recommendations designed primarily to help the veterinary clinician in the management of canine leishmaniosis. The complexity of this zoonotic infection and the wide range of its clinical manifestations, from inapparent infection to severe disease, make the management of canine leishmaniosis challenging. The recommendations were constructed by combining a comprehensive review of evidence-based studies, extensive clinical experience and critical consensus opinion discussions. The guidelines presented here in a short version with graphical topic displays suggest standardized and rational approaches to the diagnosis, treatment, follow-up, control and prevention of canine leishmaniosis. A staging system that divides the disease into four stages is aimed at assisting the clinician in determining the appropriate therapy, forecasting prognosis, and implementing follow-up steps required for the management of the leishmaniosis patient.

No abstract

No abstract

No abstract

We studied and compared the prevalence of Leishmania infection and the seroprevalence and the prevalence of canine leishmaniasis in an area where canine leishmaniasis is endemic. One hundred dogs living on the island of Mallorca (Spain) were studied. In this study, we clinically examined each dog for the presence of symptoms compatible with leishmaniasis, determined the titer of anti-Leishmania antibodies, and investigated the presence of Leishmania DNA by PCR in skin, conjunctiva, and bone marrow samples of each dog. The prevalence of the disease and the seroprevalence were 13 and 26%, respectively. In 63% of the dogs, Leishmania DNA could be detected by PCR in at least one of the tissues studied. The results of positive PCR in the bone marrow, the conjunctiva, and the skin were 17.8, 32, and 51%, respectively. The prevalence of the infection, 67%, was calculated using all animals that were seropositive and/or positive by PCR with any tissue. The results showed that the majority of dogs living in an area where canine leishmaniasis is endemic are infected by Leishmania and that the prevalence of infection is much greater than the prevalence of overt Leishmaniarelated disease.Canine leishmaniasis is a severe systemic disease of dogs caused by the protozoan parasite Leishmania infantum. Clinical manifestations of the disease include nonpruritic skin lesions, such as exfoliative dermatitis and ulcerations, local or generalized lymphadenopathy, loss of weight, poor appetite, ocular lesions, epistaxis, lameness, renal failure, and diarrhea (5,9,14,25). Leishmaniasis is a zoonotic disease for which dogs are considered the chief reservoir of the parasite. The disease is endemic in the Mediterranean basin, where seroprevalence ranges between 10 and 37% (10, 24). There are, however, several studies suggesting that the rate of infection is higher than the figures found by serological investigations. A survey performed using the PCR and immunoblotting techniques found that most dogs living in southern France had been exposed to Leishmania (3). These results agree with another study that found a rate of Leishmania infection of 65% for dogs living in Portugal by using serology and cell-mediated tests (4).The percentage of infected dogs living in an area where canine leishmaniasis is endemic has major public health implications. It was demonstrated that infected, but asymptomatic, dogs were sources of the parasite for phlebotomine vector sandflies and as a consequence play an active role in the transmission of Leishmania (15).The present study was designed to investigate and compare the prevalence of Leishmania infection, the seroprevalence and the prevalence of the disease in a canine population living in an area where canine leishmaniasis is endemic. One hundred dogs living on the island of Mallorca (Spain) were included in this study. Veterinarians clinically examined all dogs, and the titer of anti-Leishmania antibodies was determined. The presence of Leishmania DNA in each dog was investigated by PCR with three tissues: ...